A Platform Study Based on Specific Tracer for Evaluating the Therapeutic Efficacy of Systemic Treatment for Breast Cancer Using PET/MRI
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Breast Cancer
Related studies linked through entity extraction aliases.
Grape Polyphenols for Prevention of Chemotherapy-Induced Cardiotoxicity
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Additional Imaging Methods for Assessing Axillary Lymph Node Involvement in Breast Cancer
- Status
- COMPLETED
- Phase
- NA
Studying the Role of Circulating Tumor Cell Clusters in Patients With High-risk Early Breast Cancer, Study GALIA
- Status
- RECRUITING
- Phase
- NA
Evaluation of the Impact of Pre-habilitation Using Physiotherapy and Mechanical Stimulation on Shoulder Pain and Mobility in Patients Undergoing Breast Reconstruction Using a Latissimus Dorsi Flap
- Status
- NOT_YET_RECRUITING
- Phase
- NA
SHR-A1811 vs Pyrotinib/Capecitabine in Trastuzumab-Resistant HER2+ Advanced Breast Cancer: A Randomized Study
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Web-Based Application for Monitoring Radiation Therapy Complications in Cancer Patients
- Status
- RECRUITING
- Phase
- NA
BRCA1, RASSF1A and PTEN Methylation in Breast Lesions of Uncertain Malignant Potential
- Status
- COMPLETED
- Phase
- NA
Trastuzumab Rezetecan vs Trastuzumab Deruxtecan in the Neoadjuvant Treatment of HER2 Positive Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Pedicled Lateral Chest Wall Lymph-Adipofascial Flap to Prevent Arm Lymphedema After Breast Cancer Surgery
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Confirmation of the Link Between Endocrine Disruptors Exposure and Breast Cancer and Identification of Biological Response Biomarkers
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Comparison of Safety and Patients-Reported Outcomes Between Single-Port Endoscopic and Conventional Nipple-Sparing Mastectomy With Immediate Implant Reconstruction
- Status
- COMPLETED
- Phase
- N/A
Neoadjuvant Imlunestrant Plus Abemaciclib Treatment Guided by Ki67 Index After 2 Weeks for ER-Positive HER2-Negative Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Phase II Exploratory Study of Toripalimab Combined With SBRT in HER2-Negative Breast Cancer Patients With Insensitivity to Neoadjuvant Chemotherapy
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Efficacy and Safety of Hyperbaric Oxygen Therapy in Improving Nab-paclitaxel-Induced Peripheral Neuropathy
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
Impact of an Artificial Intelligence-Based Management Model on Psychological and Behavioral Outcomes in Breast Cancer Patients Undergoing Home CDK4/6 Inhibitor Therapy
- Status
- ENROLLING_BY_INVITATION
- Phase
- NA
Study of the Kinesin Oral Molecular Degrader BBI-940 in Subjects With Advanced or Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Real-world Studies of CDK4/6 Inhibitors
- Status
- RECRUITING
- Phase
- N/A
Immune Tumor Stroma Factors and Pathologic Complete Response After Neoadjuvant Chemotherapy in Early Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA